Dr. Kesavapany received his undergraduate degree in biochemistry and doctoral degree in molecular neuroscience from the Institute of Psychiatry, King’s College London. Later, Dr. Kesavapany carried out post-doctoral work at the National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health, and then joined the Department of Biochemistry of the National University of Singapore as an Assistant Professor. Starting in 2009, Dr. Kesavapany took a position at GlaxoSmithKline to lead their Neural Pathways Discovery Performance Unit and later became Director of Drug Discovery at Nanyang Technological University. Dr. Kesavapany is passionate about finding ways to make better medicines for patients. At Marquette, Dr. Kesavapany brings his academic, pharma drug discovery, academic drug discovery and technology transfer experience over the last 20 years to his role as Director of the Biomedical Sciences 4-Cyte Therapeutics, part of 4-Cyte Collaborative. 4-Cyte Therapeutics is responsible for translating innovative research by BISC faculty into therapeutics. Dr. Kesavapany is cultivating networks internally at Marquette, Wisconsin wide, and across the US and globally in other institutions and contract research organizations to achieve our aims.
​